The loss of PAX1 function caused by PAX1 methylation may affect the immune function, whereas demethylation caused by radiotherapy reactivates the normal regulatory function of PAX1 on the immune system, causing changes in tumor microenvironment and affecting radiosensitivity. Here, PAX1 is linked to neoplasm.